Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > REGULATORY
REGULATORY
- Health Minister Ready to Discuss Telemedicine Rollout, but Wants to Ensure Peace of Mind for Patients
September 24, 2020
- PMDA to Continue Remote GCP/Compliance Inspections through End of March 2021
September 24, 2020
- Japan’s COVAX Participation Meant to Confirm Importance of Global Access to Vaccines: Minister
September 23, 2020
- MHLW Grants Orphan Status to 5 APIs
September 23, 2020
- HPV Vaccine Advocate Junko Mihara Picked as Vice MHLW Chief
September 23, 2020
- MHLW Panel Members Call for Special Consideration for Pricing of “Specific-Use Drugs”
September 18, 2020
- MHLW Panel Determines Unmet Medical Needs for 10 Drugs at Its 1st Online Meeting
September 18, 2020
- Health Minister Vows to Gauge Impact on Medical Institutions in Discussing Off-Year Re-Pricing
September 18, 2020
- New Japan PM Sticks to Abe’s Goal to Secure Coronavirus Vaccines for Whole Population by H1 2021
September 17, 2020
- Ex-Health Minister Tamura Comes Back as MHLW Chief
September 16, 2020
- Japan Inks COVAX Pact with Optional Arrangement, Commits 17.2 Billion Yen Upfront
September 16, 2020
- New Vice Health Minister Aiming to Get Coronavirus Drugs and Vaccines to Japanese People “as Quickly as Possible”
September 16, 2020
- MHLW Panel Allows Osaka Univ. Hospital to Continue JANP Study, Requires Report by Year End: Data Scandal
September 15, 2020
- Prioritized Flu Vaccinations for Elderly from October 1, Others Asked to Wait until October 26
September 14, 2020
- Japan to Officially Sign Up for COVAX Pact; Govt to Hammer Out Payment on Sept. 15
September 14, 2020
- Komeito Prods Govt to Tap State Coffers for Coronavirus Vaccinations
September 11, 2020
- MHLW Calls for Smooth Supply of Flu Shots as It Anticipates Surging Demand
September 11, 2020
- Japan to Steadily Collect Info on AstraZeneca Trial Pause: Minister
September 11, 2020
- Japan to Require Pledges from Troubled Generic Makers to Skip Next Listing Round If Supply Issues Occur Again
September 10, 2020
- Label Revisions Ordered for Plaquenil, Relumina
September 10, 2020
ページ
More than a year after Dupixent (dupilumab) became the first antibody therapy approved for COPD in Japan, drug makers are…
A few weeks ago, I had coffee with a very talented executive. Let’s call him Kenji. He has a great job, a big salary, and a solid team. But he was unhappy. He felt bored and wanted a new challenge.…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…